The latest in Cancer Research News

• Researchers at the UT Southwestern Medical Center have developed a nanoparticle vaccine immunotherapy that targets several different cancer types. The nanoparticle vaccine delivers minuscule particulates that stimulate the immune system to mount an immune response.  Read more about the vaccine in Nature Nanotechnology.
• A study led by researchers at Keele University shows that men and women suffering from heart failure have a higher risk of death than people with most common types of cancer. The data for this study was collected between 2000-2011 and from 393 general practices in Scotland.  The study results were published in the European Journal of Heart Failure.
• Scientists at the University of Texas at Austin are using supercomputers developed and deployed by Texas Advanced Computing Center (TACC) to identify new and better chemo drugs. Read more in Scientific Reports.
• Patients who expressed the tumor antigen NY-ESO-1 had more aggressive cancers and were more likely to die early from their disease, according to a study led by researchers at Roswell Park Cancer Institute.  Their findings were published in the journal Gynecologic Oncology.